Please assess the completion status of the following clinical trial:

Trial Title: Superiority of ArTiMist Versus Quinine in Children With Severe Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. The patient's legally acceptable representative has provided informed consent and the patient has assented (where relevant) to participation in the trial~2. The patient is a child that weighs between 5.00 kg and 15.00 kg inclusive~3. The patient has falciparum malaria as evidenced by thick or thin blood smears of ≥ 500 P Falciparum per mcl (patients with mixed infections may be included provided ≥ 500 P Falciparum per mcl)~4. The patient has either:~   * severe or complicated falciparum malaria as determined by the investigator based on the WHO criteria for severity, and/or~  * uncomplicated falciparum malaria but is unable to tolerate oral medication as a result of gastrointestinal complications such as vomiting or diarrhoea.~Exclusion Criteria:~1. The patient's legally acceptable representative does not provide informed consent for participation, or the child if capable, does not assent to participation in the trial.~2. Ability to tolerate oral therapy~3. Patient has received any antimalarial therapy within the 7 days prior to first study drug administration.~4. Patient has evidence of significant co-infections (this does not include mixed Plasmodium infections).~5. Patient has a contraindication, allergy or is otherwise intolerant to either artemether or quinine .

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ArTiMist (Type: EXPERIMENTAL): None
- Quinine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).